Bedaquiline Roll-out Evidence in Contacts and People Living With HIV to Prevent TB
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hnseb (hospital Nacional Sergio E. Bernales)
Lima, Peru
Not, yet, recruiting - Ses Policlinico
Lima, Peru
Not, yet, recruiting
- Kilimanjaro Clinical Research Institute
Moshi, Tanzania
Recruiting
- Joint Clinical Research Centre
Kampala, Uganda
Recruiting - Mu-Jhu Care Ltd.
Kampala, Uganda
Recruiting - Makerere Lung Institute
Kampala, Uganda
Not, yet, recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 8 May 2026
- Primary completion
- 31 Jul 2027
- Completion
- 30 Sept 2027
- Last update posted
- 3 Jun 2026
- Registered enrollment
- 2,530
- Registry id
- NCT06568484
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.